|
- Packer L, Tritschler HJ. Antioxidant
properties and clinical applications of alpha-lipoic acid and
dihidrolipoic acid. In Cadenas E, Packer L. Handbook of Antioxidants.
New York: Marcel Dekker, 1996: 545-91.
- Jacob S, Ruus P, Hermann R, Tritschler
HJ, Maerker E, Renn W, Augustin HJ, Dietze GJ, Rett K. Oral
administration of rac-alpha-lipoic acid modulates insulin sensitivity
in patients with type-2 diabetes mellitus: a placebo-controlled pilot
trial. Free Radic Biol Med. 1999 Aug;27(3-4):309-14.
- Ziegler D, Reljanovic M, Mehnert H,
Gries FA. Alpha-lipoic acid in the treatment of diabetic
polyneuropathy in Germany: current evidence from clinical trials. Exp
Clin Endocrinol Diabetes. 1999;107(7):421-30.
- Morcos M, Borcea V, Isermann B, Gehrke
S, Ehret T, Henkels M, Schiekofer S, Hofmann M, Amiral J, Tritschler
H, Ziegler R, Wahl P, Nawroth PP. Effect of alpha-lipoic acid on the
progression of endothelial cell damage and albuminuria in patients
with diabetes mellitus: an exploratory study. Diabetes Res Clin Pract.
2001 Jun;52(3):175-83.
- Valenzuela A, Morgado N. Trans fatty
acid isomers in human health and in the food industry. Biol Res.
1999;32(4):273-87.
- Hu FB, Stampfer MJ, Manson JE, Rimm E,
Colditz GA, Rosner BA, Hennekens CH, Willett WC. Dietary fat intake
and the risk of coronary heart disease in women. N Engl J Med. 1997
Nov 20;337(21):1491-9.
- Salmeron J, Hu FB, Manson JE, Stampfer
MJ, Colditz GA, Rimm EB, Willett WC. Dietary fat intake and risk of
type 2 diabetes in women. Am J Clin Nutr. 2001 Jun;73(6):1019-26.
- Zimmer G, Mainka L, Ulrich H. ATP
synthesis and ATPase activities in heart mitoplasts under influence of
R(+)- and S(-)-enantiomers of lipoic acid. Methods Enzymol.
1995;251:332-40.
- Rao G. Insulin resistance syndrome. Am
Fam Physician. 2001 Mar 15;63(6):1159-63, 1165-6.
- Kwiterovich PO Jr. The metabolic
pathways of high-density lipoprotein, low-density lipoprotein, and
triglycerides: a current review. Am J Cardiol. 2000 Dec
21;86(12A):5L-10L.
- Egan BM, Greene EL, Goodfriend TL.
Nonesterified fatty acids in blood pressure control and cardiovascular
complications. Curr Hypertens Rep. 2001 Apr;3(2):107-16.
- Yip J, Facchini FS, Reaven GM.
Resistance to insulin-mediated glucose disposal as a predictor of
cardiovascular disease. J Clin Endocrinol Metab. 1998
Aug;83(8):2773-6.
- Jouven X, Charles MA, Desnos M,
Ducimetiere P. Circulating nonesterified fatty acid level as a
predictive risk factor for sudden death in the population.
Circulation. 2001 Aug 14;104(7):756-61.
- Konrad T, Vicini P, Kusterer K, Hoflich
A, Assadkhani A, Bohles HJ, Sewell A, Tritschler HJ, Cobelli C, Usadel
KH. alpha-Lipoic acid treatment decreases serum lactate and pyruvate
concentrations and improves glucose effectiveness in lean and obese
patients with type 2 diabetes. Diabetes Care. 1999 Feb;22(2):280-7.
- Jacob S, Henriksen EJ, Schiemann AL,
Simon I, Clancy DE, Tritschler HJ, Jung WI, Augustin HJ, Dietze GJ.
Enhancement of glucose disposal in patients with type 2 diabetes by
alpha-lipoicacid. Arzneimittelforschung. 1995 Aug;45(8):872-4.
- Estrada DE, Ewart HS, Tsakiridis T,
Volchuk A, Ramlal T, Tritschler H, Klip A. Stimulation of glucose
uptake by the natural coenzyme alpha-lipoic acid/thioctic acid:
participation of elements of the insulin signaling pathway. Diabetes.
1996 Dec;45(12):1798-804.
- Yaworsky K, Somwar R, Ramlal T,
Tritschler HJ, Klip A. Engagement of the insulin-sensitive pathway in
the stimulation of glucose transport by alpha-lipoic acid in 3T3-L1
adipocytes. Diabetologia. 2000 Mar;43(3):294-303.
- Streeper RS, Henriksen EJ, Jacob S,
Hokama JY, Fogt DL, Tritschler HJ. Differential effects of lipoic acid
stereoisomers on glucose metabolism in insulin-resistant skeletal
muscle. Am J Physiol. 1997 Jul;273(1 Pt 1):E185-91.
- Konrad D, Somwar R, Sweeney G, Yaworsky
K, Hayashi M, Ramlal T, Klip A. The antihyperglycemic drug alpha-lipoic
acid stimulates glucose uptake via both GLUT4 translocation and GLUT4
activation: potential role of p38 mitogen-activated protein kinase in
GLUT4 activation. Diabetes. 2001 Jun;50(6):1464-71.
- Loeblein K, Rett K, Maerker E,
Tritschler HJ, Wessel K, Wicklmayr M, Haring HU. Thioctic acid
stimulates translocation of glucose transports in hearts of
insulin-resistant Zucker rats. Diabetologia. 1995 Aug;
38(1):A132(Abs512).
- Hermann R, Niebch G. Human
pharmacokinetics of ?-lipoic acid. In Fuchs J, Packer L, Zimmer G (eds),
Lipoic Acid in Health and Disease. 1997; New York: Marcel Dekker Inc,
337-60.
- Podda M, Tritschler HJ, Ulrich H, Packer
L. Alpha-lipoic acid supplementation prevents symptoms of vitamin E
deficiency. Biochem Biophys Res Commun. 1994 Oct 14;204(1):98-104.
- Breithaupt-Grogler K, Niebch G,
Schneider E, Erb K, Hermann R, Blume HH, Schug BS, Belz GG.
Dose-proportionality of oral thioctic acid--coincidence of assessments
via pooled plasma and individual data. Eur J Pharm Sci. 1999
Apr;8(1):57-65.
- Hermann R, Niebch G. "Human
pharmacokinetics of a-lipoic acid." In Fuchs J, Packer L, Zimmer
G (eds), Lipoic Acid in Health and Disease. 1997; New York: Marcel
Dekker Inc, 337-60.
- Gleiter CH, Schug BS, Hermann R, Elze M,
Blume HH, Gundert-Remy U. Influence of food intake on the
bioavailability of thioctic acid enantiomers. Eur J Clin Pharmacol.
1996;50(6):513-4.
- Maitra I, Serbinova E, Tritschler HJ,
Packer L. Stereospecific effects of R(+)-Lipoic Acid on buthionine
sulfoximine-induced cataract formation in newborn rats. Biochem
Biophys Res Commun. 1996 Apr 16;221(2):422-9.
- Biewenga GP, Haenen GR, Bast A. The
pharmacology of the antioxidant lipoic acid. Gen Pharmacol. 1997
Sep;29(3):315-31.
- Morikawa T, Yasuno R, Wada H. Do
mammalian cells synthesize lipoic acid? Identification of a mouse cDNA
encoding a lipoic acid synthase located in mitochondria. FEBS Lett.
2001 Jun 1;498(1):16-21.
- Handelman GJ, Han D, Tritschler H,
Packer L. Alpha-lipoic acid reduction by mammalian cells to the
dithiol form, and release into the culture medium. Biochem Pharmacol.
1994 May 18;47(10):1725-30.
- Kozlov AV, Gille L, Staniek K, Nohl H.
Dihydrolipoic acid maintains ubiquinone in the antioxidant active form
by two-electron reduction of ubiquinone and one-electron reduction of
ubisemiquinone. Arch Biochem Biophys. 1999 Mar 1;363(1):148-54.
- Suzuki YJ, Tsuchiya M, Packer L.
Antioxidant activities of dihydrolipoic acid and its structural
homologues. Free Radic Res Commun. 1993;18(2):115-22.
- Schonheit K, Gille L, Nohl H. Effect of
alpha-lipoic acid and dihydrolipoic acid on ischemia/reperfusion
injury of the heart and heart mitochondria. Biochim Biophys Acta. 1995
Jun 9;1271(2-3):335-42.
- Biewenga GP, Veening-Griffioen DH,
Nicastia AJ, Haenen GR, Bast A. Effects of dihydrolipoic acid on
peptide methionine sulfoxide reductase. Arzneimittelforschung. 1998
Feb;48(2):144-8.
- Biewenga GP, Dorstijn MA, Verhagen JV,
Haenen GR, Bast A. Reduction of lipoic acid by lipoamide dehydrogenase.
Biochem Pharmacol. 1996 Feb 9;51(3):233-8.
- Loffelhardt S, Bonaventura C, Locher M,
Borbe HO, Bisswanger H. Interaction of alpha-lipoic acid enantiomers
and homologues with the enzyme components of the mammalian pyruvate
dehydrogenase complex. Biochem Pharmacol. 1995 Aug 25;50(5):637-46.
- Haramaki N, Han D, Handelman GJ,
Tritschler HJ, Packer L. Cytosolic and mitochondrial systems for NADH-
and NADPH-dependent reduction of alpha-lipoic acid. Free Radic Biol
Med. 1997;22(3):535-42.
- Exner R, Wessner B, Manhart N, Roth E.
Therapeutic potential of glutathione. Wien Klin Wochenschr. 2000 Jul
28;112(14):610-6.
- Hagen TM, Vinarsky V, Wehr CM, Ames BN.
(R)-alpha-lipoic acid reverses the age-associated increase in
susceptibility of hepatocytes to tert-butylhydroperoxide both in vitro
and in vivo. Antioxid Redox Signal. 2000 Fall;2(3):473-83.
- Lockhart B, Jones C, Cuisinier C,
Villain N, Peyroulan D, Lestage P. Inhibition of L-homocysteic acid
and buthionine sulphoximine-mediated neurotoxicity in rat embryonic
neuronal cultures with alpha-lipoic acid enantiomers. Brain Res. 2000
Feb 14;855(2):292-7.
- Aguirre N, Barrionuevo M, Ramirez MJ,
Del Rio J, Lasheras B. Alpha-lipoic acid prevents
3,4-methylenedioxy-methamphetamine (MDMA)-induced neurotoxicity.
Neuroreport. 1999 Nov 26;10(17):3675-80.
- Rybak LP, Husain K, Whitworth C, Somani
SM. Dose dependent protection by lipoic acid against cisplatin-induced
ototoxicity in rats: antioxidant defense system. Toxicol Sci. 1999
Feb;47(2):195-202.
- Packer L, Tritschler HJ, Wessel K.
Neuroprotection by the metabolic antioxidant alpha-lipoic acid. Free
Radic Biol Med. 1997;22(1-2):359-78.
- McGahon BM, Martin DS, Horrobin DF,
Lynch MA. Age-related changes in LTP and antioxidant defenses are
reversed by an alpha-lipoic acid-enriched diet. Neurobiol Aging. 1999
Nov-Dec;20(6):655-64.
- Sayre LM, Perry G, Atwood CS, Smith MA.
The role of metals in neurodegenerative diseases. Cell Mol Biol
(Noisy-le-grand). 2000 Jun;46(4):731-41.
- Graham JM, Paley MN, Grunewald RA,
Hoggard N, Griffiths PD. Brain iron deposition in Parkinson's disease
imaged using the PRIME magnetic resonance sequence. Brain. 2000
Dec;123 Pt 12:2423-31.
- Bartzokis G, Cummings J, Perlman S,
Hance DB, Mintz J. Increased basal ganglia iron levels in Huntington
disease. Arch Neurol. 1999 May;56(5):569-74.
- Richardson DR, Mouralian C, Ponka P,
Becker E. Development of potential iron chelators for the treatment of
Friedreich's ataxia: ligands that mobilize mitochondrial iron. Biochim
Biophys Acta. 2001 May 31;1536(2-3):133-40.
- Berg D, Weishaupt A, Francis MJ, Miura
N, Yang XL, Goodyer ID, Naumann M, Koltzenburg M, Reiners K, Becker G.
Changes of copper-transporting proteins and ceruloplasmin in the
lentiform nuclei in primary adult-onset dystonia. Ann Neurol. 2000
Jun;47(6):827-30.
- Sayre LM, Perry G, Harris PL, Liu Y,
Schubert KA, Smith MA. In situ oxidative catalysis by neurofibrillary
tangles and senile plaques in Alzheimer's disease: a central role for
bound transition metals. J Neurochem. 2000 Jan;74(1):270-9.
- Cherny RA, Atwood CS, Xilinas ME, Gray
DN, Jones WD, McLean CA, Barnham KJ, Volitakis I, Fraser FW, Kim Y,
Huang X, Goldstein LE, Moir RD, Lim JT, Beyreuther K, Zheng H, Tanzi
RE, Masters CL, Bush AI. Treatment with a copper-zinc chelator
markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's
disease transgenic mice. Neuron. 2001 Jun;30(3):665-76.
- Ou P, Tritschler HJ, Wolff SP. Thioctic
(lipoic) acid: a therapeutic metal-chelating antioxidant? Biochem
Pharmacol. 1995 Jun 29;50(1):123-6.
- Muller L, Menzel H. Studies on the
efficacy of lipoate and dihydrolipoate in the alteration of cadmium2+
toxicity in isolated hepatocytes. Biochim Biophys Acta. 1990 May
22;1052(3):386-91.
- Suh J, Rocha A, Shigeno E, Frei B, Hagen
TM. (R)-alpha-lipoic acid supplementation of old rats decreases
age-dependent accumulation of iron and ascorbate depletion in brain.
AGE. 1999 Jul; 22(3):121(Abs 19).
- Shigenaga MK, Hagen TM, Ames BN.
Oxidative damage and mitochondrial decay in aging. PNAS. 1994 Nov
8;91(23):10771-8.
- Herrero A, Barja G. Effect of aging on
mitochondrial and nuclear DNA oxidative damage in the heart and brain
throughout the life-span of the rat. J Amer Aging Assoc. 2001
Apr;24(2):45-50.
|
|
